Biomet Vanguard Minimally Invasive Knee System To Launch By November
This article was originally published in The Gray Sheet
Executive Summary
Biomet believes its Vanguard series instrumented, minimally invasive unicondylar knee system will help grow the company's 40% U.S. market share in unicompartmental knees